Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$411,605
in 5 filings

Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-07-03 Ondrey Aaron Chief Financial Officer Sale −1,477 $2.88 $4K 128,173
2025-04-04 Ondrey Aaron Chief Financial Officer Sale −7,489 $5.29 $40K 129,650
2025-02-11 Ondrey Aaron Chief Financial Officer Grant or award +90,358 137,139
2025-02-11 Ondrey Aaron Chief Financial Officer Grant or award · Stock Option (Right to Buy) +134,642 134,642
2024-04-01 Ondrey Aaron Chief Financial Officer Grant or award +46,781 46,781
2024-04-01 Ondrey Aaron Chief Financial Officer Grant or award · Stock Option (Right to Buy) +69,337 69,337

Page 1 of 1 · 6 trades